StopDown
Unicorn India Ventures logo
Stake sale · 17 July 2024Unicorn India VenturesUnicorn India Venturesunicornivc.com ↗
Stake sale

Unicorn India Ventures partly exits Sascan Meditech

By · Editor ·

Mumbai
  • The fund sold part of its holding in Thiruvananthapuram cancer-screening maker Sascan Meditech, earning about six times its money on the exit
  • It had put ₹2 crore into the company across two rounds, first in 2020 as its earliest institutional backer, then again in 2021
  • The fund keeps a sizeable stake, and Sascan's products include OralScan for oral cancer screening and CerviScan for cervical examination

What happened

  • Unicorn India Ventures made a partial exit (selling part of its stake) from Sascan Meditech.
  • The exit returned about 6x the money to the fund.
  • It had invested ₹2 crore over two rounds, in 2020 and 2021.
  • The fund still holds a substantial stake in the company.
  • Sascan was founded in 2015 by laser scientist Dr Subhash Narayanan.

Read it as a card in the app

Terms in this story

  • Unicorn: A unicorn is a privately held startup valued at $1 billion or more, roughly ₹8,000 to ₹9,000 crore as of November 2026. India's count depends on who counts: Tracxn listed 131 in May 2026, while the Hurun Global Unicorn Index named 61 in June 2026, ranking India fourth in the world.
  • Unicorn: A unicorn is a private startup valued at $1 billion or more, and a decacorn is valued at $10 billion or more. A soonicorn is an informal label for a company that looks close to the first line, roughly $500 million to $1 billion. These are labels, not legal categories.

Everything on Unicorn India Ventures → · All startup news on 17 July 2024 →

Is this Unicorn India Ventures? Get your “Featured on StopDown” badge →